This is a proposal to renew an ongoing and successful postdoctoral clinical research training program on the human behavioral pharmacology of substance abuse. Ten training positions are proposed, all at the postdoctoral level. Training duration is two years. The goal is to produce experts in various aspects of substance abuse, psychopharmacology, and treatment who go on to succeed as independent clinical researchers, scientists, academicians, and administrators in drug abuse and related fields. Major themes of the research training are: (a) Clinical pharmacology of drug abuse and of medications for treating drug abuse; (b) Behavioral and pharmacological treatments for drug abuse, and their integration; and (c) Psychiatric comorbidity and behavioral assessment of drug abusers. Training consists primarily of conducting supervised clinical research in collaboration with training faculty and analyzing and publishing the results of that research. In addition, trainees present reports at major scientific meetings and participate in an organized program of educational seminars designed to provide both breadth and depth to their knowledge and skills relevant to drug abuse and clinical research. The training program site is a multifaceted drug abuse clinical research program - the Behavioral Pharmacology Research Unit - plus other affiliated drug abuse treatment and research programs at the same campus. Research training will be provided in the following specific areas: clinical pharmacology of drugs of abuse; medications development research; cognitive and behavioral toxicity of drugs of abuse; abuse liability assessment; behavioral treatment of drug abuse; pharmacological treatment of drug abuse; integration of behavioral and pharmacological treatments; psychiatric comorbidity; behavioral assessment; HIV risk behavior assessment; clinical trials research methods and management; addiction and pregnancy; and women?s health issues.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Institutional National Research Service Award (T32)
Project #
5T32DA007209-22
Application #
6515450
Study Section
Human Development Research Subcommittee (NIDA)
Program Officer
Babecki, Beth
Project Start
1981-02-01
Project End
2006-06-30
Budget Start
2002-07-01
Budget End
2003-06-30
Support Year
22
Fiscal Year
2002
Total Cost
$377,854
Indirect Cost
Name
Johns Hopkins University
Department
Psychiatry
Type
Schools of Medicine
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Jarvis, Brantley P; Holtyn, August F; Berry, Meredith S et al. (2018) Predictors of induction onto extended-release naltrexone among unemployed heroin-dependent adults. J Subst Abuse Treat 85:38-44
Sweeney, Mary M; Rass, Olga; DiClemente, Cara et al. (2018) Working Memory Training for Adolescents With Cannabis Use Disorders: A Randomized Controlled Trial. J Child Adolesc Subst Abuse 27:211-226
Silverman, Kenneth; Holtyn, August F; Subramaniam, Shrinidhi (2018) Behavior analysts in the war on poverty: Developing an operant antipoverty program. Exp Clin Psychopharmacol 26:515-524
Carbonaro, Theresa M; Johnson, Matthew W; Hurwitz, Ethan et al. (2018) Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences. Psychopharmacology (Berl) 235:521-534
Jarvis, Brantley P; DeFulio, Anthony; Long, Lauren et al. (2018) Factors associated with using opiates while under extended-release naltrexone blockade: A descriptive pilot study. J Subst Abuse Treat 85:56-60
Huhn, Andrew S; Garcia-Romeu, Albert Perez; Dunn, Kelly E (2018) Opioid Overdose Education for Individuals Prescribed Opioids for Pain Management: Randomized Comparison of Two Computer-Based Interventions. Front Psychiatry 9:34
Morris, David H; Davis, Alan K; Lauritsen, Kirstin J et al. (2018) Substance use consequences, mental health problems, and readiness to change among Veterans seeking substance use treatment. J Subst Abuse Treat 94:113-121
Pacek, Lauren R; McClernon, F Joseph; Rass, Olga et al. (2018) Perceived risk of developing smoking-related disease among persons living with HIV. AIDS Care 30:1329-1334
Jarvis, Brantley P; Holtyn, August F; Subramaniam, Shrinidhi et al. (2018) Extended-release injectable naltrexone for opioid use disorder: a systematic review. Addiction 113:1188-1209
Huhn, Andrew S; Berry, Meredith S; Dunn, Kelly E (2018) Systematic review of sex-based differences in opioid-based effects. Int Rev Psychiatry :1-10

Showing the most recent 10 out of 288 publications